Matches in SemOpenAlex for { <https://semopenalex.org/work/W2155641013> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2155641013 endingPage "i69" @default.
- W2155641013 startingPage "i65" @default.
- W2155641013 abstract "Nowadays, drug development requires large-scale studies to show the real clinical benefit for the patients, which means recruiting a sufficient number of patients, even internationally. As global studies enable simultaneous delivery of new drugs and sharing of safety information around the world, multinational studies now account for around 20% of Japanese clinical studies. Until recently, drug development has been centered in Western countries, but interest in Asian regions has increased. In this environment, one important factor in drug development is ethnicity. Various cancers show regional patterns in their incidence, and some (such as liver cancer and gastric cancer) show high incidences in Asian countries. Ethnic factors including genetic differences, such as the CYP drug-metabolizing enzymes in the liver and gene mutations, may result in different drug responses in terms of efficacy and safety. Examples of ethnic differences in drug responses were seen with gefitinib, which showed a different efficacy data, and with sunitinib, showing a clearly different toxicity profile between the West and Asia. Therefore, ethnic differences need to be taken into account in the early phase of drug development, and Asian countries need to be involved early in clinical development. Asian collaboration among physicians and networks of specialists is also important, and there is good potential for successful establishment of the infrastructure needed for collaborative clinical trials. Establishment of a so-called third development center in Asian countries that will complement the USA and European centers is highly desired." @default.
- W2155641013 created "2016-06-24" @default.
- W2155641013 creator A5000861230 @default.
- W2155641013 creator A5022155485 @default.
- W2155641013 creator A5051803042 @default.
- W2155641013 date "2010-09-01" @default.
- W2155641013 modified "2023-10-04" @default.
- W2155641013 title "Clinical Trials and Approval of Anti-cancer Agents" @default.
- W2155641013 cites W2049767844 @default.
- W2155641013 cites W2153477391 @default.
- W2155641013 cites W2161821474 @default.
- W2155641013 cites W2217809488 @default.
- W2155641013 doi "https://doi.org/10.1093/jjco/hyq129" @default.
- W2155641013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20870922" @default.
- W2155641013 hasPublicationYear "2010" @default.
- W2155641013 type Work @default.
- W2155641013 sameAs 2155641013 @default.
- W2155641013 citedByCount "4" @default.
- W2155641013 countsByYear W21556410132012 @default.
- W2155641013 countsByYear W21556410132016 @default.
- W2155641013 countsByYear W21556410132017 @default.
- W2155641013 crossrefType "journal-article" @default.
- W2155641013 hasAuthorship W2155641013A5000861230 @default.
- W2155641013 hasAuthorship W2155641013A5022155485 @default.
- W2155641013 hasAuthorship W2155641013A5051803042 @default.
- W2155641013 hasBestOaLocation W21556410131 @default.
- W2155641013 hasConcept C121608353 @default.
- W2155641013 hasConcept C126322002 @default.
- W2155641013 hasConcept C137403100 @default.
- W2155641013 hasConcept C144024400 @default.
- W2155641013 hasConcept C19165224 @default.
- W2155641013 hasConcept C2776264508 @default.
- W2155641013 hasConcept C2778019345 @default.
- W2155641013 hasConcept C2778695046 @default.
- W2155641013 hasConcept C2779490328 @default.
- W2155641013 hasConcept C2780035454 @default.
- W2155641013 hasConcept C535046627 @default.
- W2155641013 hasConcept C64903051 @default.
- W2155641013 hasConcept C71924100 @default.
- W2155641013 hasConcept C98274493 @default.
- W2155641013 hasConceptScore W2155641013C121608353 @default.
- W2155641013 hasConceptScore W2155641013C126322002 @default.
- W2155641013 hasConceptScore W2155641013C137403100 @default.
- W2155641013 hasConceptScore W2155641013C144024400 @default.
- W2155641013 hasConceptScore W2155641013C19165224 @default.
- W2155641013 hasConceptScore W2155641013C2776264508 @default.
- W2155641013 hasConceptScore W2155641013C2778019345 @default.
- W2155641013 hasConceptScore W2155641013C2778695046 @default.
- W2155641013 hasConceptScore W2155641013C2779490328 @default.
- W2155641013 hasConceptScore W2155641013C2780035454 @default.
- W2155641013 hasConceptScore W2155641013C535046627 @default.
- W2155641013 hasConceptScore W2155641013C64903051 @default.
- W2155641013 hasConceptScore W2155641013C71924100 @default.
- W2155641013 hasConceptScore W2155641013C98274493 @default.
- W2155641013 hasIssue "Supplement 1" @default.
- W2155641013 hasLocation W21556410131 @default.
- W2155641013 hasLocation W21556410132 @default.
- W2155641013 hasOpenAccess W2155641013 @default.
- W2155641013 hasPrimaryLocation W21556410131 @default.
- W2155641013 hasRelatedWork W2613793516 @default.
- W2155641013 hasRelatedWork W2754715246 @default.
- W2155641013 hasRelatedWork W2765713842 @default.
- W2155641013 hasRelatedWork W2792614511 @default.
- W2155641013 hasRelatedWork W2967372420 @default.
- W2155641013 hasRelatedWork W2973451075 @default.
- W2155641013 hasRelatedWork W3158717065 @default.
- W2155641013 hasRelatedWork W4205773795 @default.
- W2155641013 hasRelatedWork W4313309309 @default.
- W2155641013 hasRelatedWork W4365445318 @default.
- W2155641013 hasVolume "40" @default.
- W2155641013 isParatext "false" @default.
- W2155641013 isRetracted "false" @default.
- W2155641013 magId "2155641013" @default.
- W2155641013 workType "article" @default.